Oakley Capital Investments expertise incrementally improves investee companies – Hardman & Co (LON:OCI) 10 June 2022
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
Oncimmune new ImmunoINSIGHTS contract further validates offering and supports expected sales growth 26 July 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Potential Upside in Residential Construction 19 January 2026
Spirax Group PLC (SPX.L) Stock Analysis: Evaluating the 8.62% Upside Potential for Investors 19 January 2026
Whitbread PLC (WTB.L) Stock Analysis: Navigating the Potential Upside in a Challenging Market 19 January 2026
Smiths Group PLC (SMIN.L) Stock Analysis: Navigating Industrial Innovation with a 2.90% Upside Potential 19 January 2026
Vodafone Group PLC (VOD.L) Stock Analysis: Navigating the Telecom Giant’s 3.9% Dividend Yield Amidst Mixed Ratings 19 January 2026
Oakley Capital Investments expertise incrementally improves investee companies – Hardman & Co (LON:OCI) 10 June 2022
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
Oncimmune new ImmunoINSIGHTS contract further validates offering and supports expected sales growth 26 July 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Potential Upside in Residential Construction 19 January 2026
Spirax Group PLC (SPX.L) Stock Analysis: Evaluating the 8.62% Upside Potential for Investors 19 January 2026
Whitbread PLC (WTB.L) Stock Analysis: Navigating the Potential Upside in a Challenging Market 19 January 2026
Smiths Group PLC (SMIN.L) Stock Analysis: Navigating Industrial Innovation with a 2.90% Upside Potential 19 January 2026
Vodafone Group PLC (VOD.L) Stock Analysis: Navigating the Telecom Giant’s 3.9% Dividend Yield Amidst Mixed Ratings 19 January 2026
NovoCure Limited (NVCR) Stock Analysis: Exploring a Potential 84% Upside in the Medical Device Arena 23 December 2025
Select Medical Holdings Corpora (SEM) Stock Analysis: Exploring a 23.57% Potential Upside 23 December 2025
Alphatec Holdings, Inc. (ATEC) Investor Outlook: Strong Buy Ratings and 18.91% Potential Upside 23 December 2025
SS Innovations International (SSII) Stock Analysis: Unpacking Rapid Revenue Growth Amid Uncertain Metrics 23 December 2025
Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 6.28% Potential Upside Amidst Robust Revenue Growth 23 December 2025
Scholar Rock Holding Corporation (SRRK): Investor Outlook on Biotech’s Potential Upside and Robust Buy Ratings 23 December 2025
Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Strong Revenue Growth and Analyst Confidence Signal Promising Upside 23 December 2025
Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Look at Its 7.32% Upside Potential 23 December 2025
LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 21% Potential Upside in the Booming Healthcare Sector 23 December 2025
Tandem Diabetes Care (TNDM) Investor Outlook: Navigating a 6.66% Upside in the Medical Devices Sector 23 December 2025
Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 62% Potential Upside Amid Analyst Optimism 23 December 2025
PACS Group, Inc. (PACS) Stock Analysis: A Robust 31% Revenue Growth Sets Stage for 15% Potential Upside 23 December 2025
UFP Technologies, Inc. (UFPT) Stock Analysis: 43% Potential Upside Sparks Investor Interest 23 December 2025
Immunocore Holdings plc (IMCR) Stock Analysis: Unveiling a 77.57% Potential Upside in the Biotech Sector 23 December 2025
Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A Biotech Pioneer with 37.8% Potential Upside 23 December 2025
Ligand Pharmaceuticals (LGND) Stock Analysis: Strong Buy Ratings Highlight 23% Upside Potential 23 December 2025
Concentra Group Holdings (CON): A Healthcare Stock with 44% Upside Potential and Strong Buy Ratings 23 December 2025
ImmunityBio, Inc. (IBRX) Stock Analysis: Biotechnology Innovator with a 358% Potential Upside 23 December 2025
Oakley Capital Investments expertise incrementally improves investee companies – Hardman & Co (LON:OCI) 10 June 2022
Oncimmune new ImmunoINSIGHTS contract further validates offering and supports expected sales growth 26 July 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Potential Upside in Residential Construction 19 January 2026
Spirax Group PLC (SPX.L) Stock Analysis: Evaluating the 8.62% Upside Potential for Investors 19 January 2026
Whitbread PLC (WTB.L) Stock Analysis: Navigating the Potential Upside in a Challenging Market 19 January 2026
Smiths Group PLC (SMIN.L) Stock Analysis: Navigating Industrial Innovation with a 2.90% Upside Potential 19 January 2026
Vodafone Group PLC (VOD.L) Stock Analysis: Navigating the Telecom Giant’s 3.9% Dividend Yield Amidst Mixed Ratings 19 January 2026
